Stock 600420 SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Shanghai Shyndec Pharmaceutical Co., Ltd.

Equities

600420

CNE000001JG2

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 2024-12-09 		5-day change 1st Jan Change
12.32 CNY +0.33% Intraday chart for Shanghai Shyndec Pharmaceutical Co., Ltd. +1.23% +25.84%
Dec. 06 Shyndec Pharma Unit's Codeine Phosphate Included in China's Listing of Chemical Raw Materials MT
Dec. 03 Shanghai Shyndec Pharmaceutical Gets Drug Registration for Eye Drops MT

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Shyndec Pharma Unit's Codeine Phosphate Included in China's Listing of Chemical Raw Materials
Dec. 05
 MT
Shanghai Shyndec Pharmaceutical Gets Drug Registration for Eye Drops
Dec. 03
 MT
Shanghai Shyndec Pharmaceutical Passes Drug Evaluation for Calcium Gluconate Injection
Nov. 27
 MT
Shanghai Shyndec Pharmaceutical CFO Resigns
Nov. 26
 MT
Shanghai Shyndec Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024
Oct. 28
 CI
China Approves Shyndec Pharmaceutical's Listing Application for Epilepsy Drug Ingredient
Sep. 05
 MT
Shyndec Pharmaceutical Gets Nod to Add Specification to Pravastatin Sodium Tablets
Aug. 30
 MT
Shyndec Pharmaceutical's H1 Profit Soars 108%, Operating Income Slips 8%
Aug. 28
 MT
Shyndec Pharmaceutical's Chairman, President Resign
Aug. 28
 MT
Shanghai Shyndec Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024
Aug. 27
 CI
Shanghai Shyndec Pharmaceutical Antibiotic Drug Passes Drug Consistency Evaluation
Aug. 12
 MT
Shanghai Shyndec Pharmaceutical's Chest Pain Drug Passes China's Drug Evaluations
Jul. 31
 MT
Shyndec Pharmaceutical's Unit Gets Nod to Amend Lipoic Acid Injection's Specification
Jul. 19
 MT
Shyndec Pharma Unit Gets Rights for Ceftazidime Avibactam Sodium for Injection
Jul. 12
 MT
Shanghai Shyndec Pharmaceutical Obtains Drug Registration for Anti-Tumor Injection; Shares Jump 9%
Jul. 09
 MT
Shyndec Pharma Unit Gets China Nod for Analgesic Ingredient
Jun. 14
 MT
Shyndec Pharma Unit Gets China Nod for Conjunctivitis Eye Drops
Jun. 14
 MT
China Grants Registration Approval for Shanghai Shyndec Pharmaceutical Unit's Flu Injection
May. 15
 MT
Shanghai Shyndec Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Apr. 29
 CI
Shyndec Pharmaceutical's Unit Gets Nod to Market Empagliflozin Tablets
Apr. 16
 MT
China stocks rise after new guidelines; HK shares drop
Apr. 15
 RE
Chinese FDA Grants Marketing Approval for Shyndec Subsidiary's Drug Raw Materials
Apr. 10
 MT
China Production Bases of Shyndec Pharmaceutical's Unit Gets Compliance Certification from Australian Regulator
Mar. 27
 MT
Shyndec Pharma's Unit Gets Regulatory Nod for Sheep Vaccine
Mar. 07
 MT
Shyndec Pharma Unit's Cefotaxime Sodium for Injection Passes Drug Regulator's Consistency Evaluation
Feb. 20
 MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 600420 Stock
  4. News Shanghai Shyndec Pharmaceutical Co., Ltd.